Intimation of the Notice of Postal Ballot (02/2026-27) dated October 08, 2026.

Evonile Pharma Limited (formerly known as Novartis India Limited) October 13, 2026 The Secretary BSE Limited, Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai - 400 001 Scrip Code – 500672 Sub.: Notice of Postal Ballot (02/2026-27) - Disclosure under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“Listing Regulations”) of Evonile Pharma Limited (formerly known as Novartis India Limited (“the Company”). Dear Sir/ Madam, It is hereby informed that the Company shall be seeking the consent of the Members through Postal Ballot via remote e-voting on the following item: - Sr. Resolution name Resolution Type 1 To approve the grant of employee stock options, equal to or Special Resolution more than 1% of the issued capital of the Company to the identified employee under Employee Stock Option Scheme 2026 2 To consider and approve the creation of charge on the Special Resolution assets of the Company under Section 180(1)(a) In this regard and pursuant to Regulation 30 (read with Para A of Part A of Schedule Ill) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('SEBI Listing Regulations') and SEBI Circular No. SEBI/HO/CFD/CFDPoD-1/P/CIR/2023/123 dated July 13, 2023, please find enclosed herewith the copy of the Notice of Postal Ballot (02/2026-27) (“the Notice”) dated Thursday, October 08, 2026 together with the Explanatory Statement annexed thereto. In conformity with the above requirements, the said Notice is being sent electronically to all the Members whose names appear in the Register of Members/ List of Beneficial Owners and whose e-mail IDs are registered with the Company/ Depositories/ Depository Participants as on Friday, October 09, 2026, being the Cut-off date (“Cut-Off Date”). To facilitate Members to receive the Notice electronically and cast their vote electronically, the Company has appointed MUFG Intime India Private Limited (Formerly known as Link Registered Office: Inspire BKC, 7th Floor, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra, India. CIN: L24200MH1947PLC006104 | Tel: +91 22 50243000 Email: investor.relations@nilpharma.co.in | Website: www.evonilepharma.com Evonile Pharma Limited (formerly known as Novartis India Limited) Intime India Private Limited) (“MUFG”) for registration of their e-mail addresses in terms of the MCA Circulars. The remote e-voting period shall commence at 9.00 A.M. (IST) on Wednesday, October 14, 2026, and will end at 5.00 P.M. (IST) on Thursday, November 12, 2026. The Result of the Postal Ballot/ remote e-voting shall be declared on or before Saturday, November 14, 2026. Thank you, Yours Sincerely, For Evonile Pharma Limited (formerly known as Novartis India Limited) Ms. Chandni Maru Company Secretary & Compliance Officer A60291 Registered Office: Inspire BKC, 7th Floor, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra, India. CIN: L24200MH1947PLC006104 | Tel: +91 22 50243000 Email: investor.relations@nilpharma.co.in | Website: www.evonilepharma.com Evonile Pharma Limited (formerly known as Novartis India Limited) EVONILE PHARMA LIMITED (formerly known as Novartis India Limited) Corporate Identification No. (CIN) – L24200MH1947PLC006104 Registered Office: Inspire - BKC, 7th Floor, Bandra Kurla Complex, Bandra (East), Mumbai - 400051 Tel: +91 022-50243000 Website: www.evonilepharma.com ; E mail: investor.relations@nilpharma.co.in NOTICE OF POSTAL BALLOT (02/2026-27) Pursuant to Section 108 and 110 of the Companies Act, 2013 (‘Act’) read with the Companies (Management and Administration) Rules, 2014 (‘Rules’) each as amended, and the applicable Circulars issued by the Ministry of Corporate Affairs (‘MCA’) E-VOTING STARTS ON E-VOTING ENDS ON 9.00 A.M. (IST) on Wednesday, October 14, 5.00 P.M. (IST) on Thursday, November 12, 2026 2026 Dear Members, NOTICE is hereby given pursuant to Sections 110 and 108 and other applicable provisions, if any, of the Companies Act, 2013, (“Act”) read with Rules 20 and 22 of the Companies (Management and Administration) Rules, 2014, (including any statutory modification or re-enactment thereof for the time being in force) (“Rules”), Regulation 44 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“SEBI Listing Regulations”), Secretarial Standards on General Meetings issued by the Institute of Company Secretaries of India (“Secretarial Standard - 2”), each as amended and in accordance with the guidelines prescribed by the Ministry of Corporate Affairs (“MCA”) for holding general meetings / conducting postal ballot process through e- voting vide General Circular Nos. 14/2020 dated April 8, 2020, 17/2020 dated April 13, 2020, 11/2022 dated December 28, 2022, 09/2023 dated September 25, 2023, 09/2024 dated September 19, 2024 and the latest being General Circular No. 03/2025 dated September 22, 2025 (“MCA Circulars”), to transact the following special business as considered in the resolutions appended below through Postal Ballot only by way of remote e-voting (“e-voting”): Sr. No. Particulars 1. To approve the grant of employee stock options, equal to or more than 1% of the issued capital of the Company to the identified employee under Employee Stock Option Scheme 2026 - (Special Resolution) 2. To consider and approve the creation of charge on the assets of the Company under Section 180(1)(a) - (Special Resolution) Registered Office: Inspire BKC, 7th Floor, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra, India. CIN: L24200MH1947PLC006104 | Tel: +91 22 50243000 Email: investor.relations@nilpharma.co.in | Website: www.evonilepharma.com Evonile Pharma Limited (formerly known as Novartis India Limited) Pursuant to Sections 102, 110 and other applicable provisions of the Act, the Statement pertaining to the said Resolutions setting out the material facts and the reason/ rationale thereof is annexed to this Notice of Postal Ballot (02/2026-27) for your consideration and forms part of this Notice of Postal Ballot (02/2026-27) ("Notice"). In compliance accordance aforesaid MCA Circulars, the Notice and e-voting instructions are being sent only by e-mail to those Members who have registered their e-mail address with their Depository Participants (“DPs”) or with MUFG Intime India Private Limited (“MUFG”) (Formerly known as Link Intime India Private Limited), Registrar to the Issue and Share Transfer Agent (“RTA”) of the Company and whose names appears in the Register of Members / List of Beneficial Owners as received from the National Securities Depository Limited (“NSDL”) and Central Depository Services (India) Limited (“CDSL”) (collectively referred to as “Depositories”) as on Friday, October 09, 2026 (“Cut-off Date”) and the communication of assent / dissent of the Members on the resolutions proposed in the Notice will take place only through the e-voting system. In compliance with Regulation 44 of the SEBI Listing Regulations and pursuant to the provisions of Sections 110 and 108 of the Act read with the Rules, the MCA Circulars and Secretarial Standard – 2, the Company is only providing e-voting facility to its Members, to enable them to cast their votes electronically instead of submitting the Postal Ballot form physically. The instructions for e-voting are appended to this Notice. The Company has engaged NSDL for the purpose of providing e-voting facility/ services to its members. The Notice is also available on the website of the Company at https://evonilepharma.com/annual- general-meeting/ Members desiring to exercise their vote through the remote e-voting process are requested to carefully read the instructions indicated in the ‘Notes’ section of this Notice and record their assent (FOR) or dissent (AGAINST) by following the procedure as stated in the Notes forming part of the Notice for casting of votes by remote e-voting not later than 05:00 p.m. (IST) on Thu [Showing first 8,000 characters — download PDF for full document]